87 results
Page 4 of 5
DRS
4knzf 0lus
18 Dec 20
Draft registration statement
12:00am
6-K
EX-99.1
ojkb1s21 wzlh480u
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
wf6nv1n6
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
spabj055t17q62379
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
6-K
EX-99.1
05813u
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
6-K
EX-99.1
0k60e0njvyyqk
6 Aug 20
Amryt Announces Q2 2020 Results and Issues Positive Revenue Guidance for Fy 2020
9:43am
424B4
iy31317k
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
jg8vzr
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-10.11.1
c6zd3cxg y86wd
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.7
kdn7sx
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.11.9
2i1 fdedwyl9gsnybm
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.1
2lei jdayhog74
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.12.5
03g8 ohl3d09n
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.6
zcvlmtj3qc46c2jp2 x9
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.11.7
b5z5clb
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-3.1
dfrvi 0zftfl9
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.5
btwk23g9pe7fo6
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
iv4gsud
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-2.1
lvripbtj7m
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
h2yaw3 ee1
29 May 20
Draft registration statement (amended)
12:00am